Literature DB >> 28163238

Extraordinary high strength Ti-Zr-Ta alloys through nanoscaled, dual-cubic spinodal reinforcement.

Arne Biesiekierski1, Dehai Ping2, Yuncang Li3, Jixing Lin4, Khurram S Munir3, Yoko Yamabe-Mitarai2, Cuie Wen5.   

Abstract

While titanium alloys represent the current state-of-the-art for orthopedic biomaterials, concerns still remain over their modulus. Circumventing this via increased porosity requires high elastic admissible strains, yet also limits traditional thermomechanical strengthening techniques. To this end, a novel β-type Ti-Zr-Ta alloy system, comprised of Ti-45Zr-10Ta, Ti-40Zr-14Ta, Ti-35Zr-18Ta and Ti-30Zr-22Ta, was designed and characterized mechanically and microstructurally. As-cast, this system displayed extremely high yield strengths and elastic admissible strains, up to 1.4GPa and potentially 1.48%, respectively. This strength was attributed to a nanoscaled, cuboidal structure of semi-coherent, dual body-centered cubic (BCC) phases, arising from the thermodynamics of interaction between Ta and Zr; this morphology occurring with dual BCC-phases is heretofore unreported in Ti-based alloys. Further, cell proliferation investigated by MTS assay suggests this was achieved without sacrificing biocompatibility, with no significant difference to either empty-well or commercially-pure Ti controls noted. STATEMENT OF SIGNIFICANCE: The current research details microstructural, mechanical, and biological investigations into four novel biomedical alloys in a hitherto uninvestigated region of the Ti-Zr-Ta alloy system; Ti-45Zr-10Ta, Ti-40Zr-14Ta, Ti-35Zr-18Ta and Ti-30Zr-22Ta. We find that the investigated alloys display 0.2% yield strengths of up to 1.40GPa and elastic admissible strains of up to 1.48%, along with biological properties comparable to that seen in the conventional metallic biomaterial ASTM Grade-2 CP-Ti, achieved in the complete absence of traditional thermomechanical processing techniques. This is attributed to the presence of a dual-BCC cuboidal nanostructure, achieved via spinodal decomposition; while similar structures have been reported in e.g. Ni-based superalloys, we believe this is the first such structure investigated in a Ti-based material. As such, this work is felt to be of great interest in aiding the design and manufacture of highly-biocompatible, porous, metallic biomaterials for orthopedic application.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomedical; Nano-structure; Spinodal decomposition; Titanium alloy; Transmission electron microscopy (TEM)

Mesh:

Substances:

Year:  2017        PMID: 28163238     DOI: 10.1016/j.actbio.2017.01.085

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

1.  Preparation, structural, microstructural, mechanical and cytotoxic characterization of as-cast Ti-25Ta-Zr alloys.

Authors:  Pedro Akira Bazaglia Kuroda; Fernanda de Freitas Quadros; Karolyne Dos Santos Jorge Sousa; Tatiani Ayako Goto Donato; Raul Oliveira de Araújo; Carlos Roberto Grandini
Journal:  J Mater Sci Mater Med       Date:  2020-01-21       Impact factor: 3.896

2.  Effect of Thermomechanical Treatments on the Phases, Microstructure, Microhardness and Young's Modulus of Ti-25Ta-Zr Alloys.

Authors:  Pedro Akira Bazaglia Kuroda; Fernanda de Freitas Quadros; Raul Oliveira de Araújo; Conrado Ramos Moreira Afonso; Carlos Roberto Grandini
Journal:  Materials (Basel)       Date:  2019-09-30       Impact factor: 3.623

3.  An investigation of the mechanical and microstructural evolution of a TiNbZr alloy with varied ageing time.

Authors:  Arne Biesiekierski; Jixing Lin; Khurram Munir; Sertan Ozan; Yuncang Li; Cuie Wen
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

Review 4.  Additive manufacturing technology for porous metal implant applications and triple minimal surface structures: A review.

Authors:  Li Yuan; Songlin Ding; Cuie Wen
Journal:  Bioact Mater       Date:  2018-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.